Literature DB >> 3565577

Volume regulatory loss of Na, Cl, and K from rat brain during acute hyponatremia.

J E Melton, C S Patlak, K D Pettigrew, H F Cserr.   

Abstract

This study quantitatively evaluates the contribution of tissue Na, Cl, and K loss to brain volume regulation during acute dilutional hyponatremia (DH) and examines the mechanism of Na loss. DH was produced in pentobarbital sodium-anesthetized rats by intraperitoneal infusion of distilled water and brain water and electrolytes analyzed 30 min, 1 h, 3 h, 4 h, or 6 h later. The rate of Na and Cl loss was greatest during the first 30 min of DH (0.43 and 0.47 meq X kg tissue dry wt-1 X min-1, respectively). Net loss of Na and Cl was maximal after 3 h of DH. K loss was slower, achieving significance after 3 h. Electrolyte loss was sufficient to account for observed brain volume regulation after three or more hours of DH. Measurements of 22Na influx and efflux across the blood-brain barrier showed that barrier permeability to Na is unchanged during DH. Analysis of results using a two-compartment model of plasma-brain exchange suggests that loss of brain Na during DH does not result solely from a shift of electrolyte across the blood-brain barrier to plasma, and thus provides indirect evidence for an additional pathway for Na loss, presumably via cerebrospinal fluid.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3565577     DOI: 10.1152/ajprenal.1987.252.4.F661

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

1.  Agonist action of taurine on glycine receptors in rat supraoptic magnocellular neurones: possible role in osmoregulation.

Authors:  N Hussy; C Deleuze; A Pantaloni; M G Desarménien; F Moos
Journal:  J Physiol       Date:  1997-08-01       Impact factor: 5.182

Review 2.  Receptor regulation of osmolyte homeostasis in neural cells.

Authors:  Stephen K Fisher; Anne M Heacock; Richard F Keep; Daniel J Foster
Journal:  J Physiol       Date:  2010-05-24       Impact factor: 5.182

3.  CSF sub-compartments in relation to plasma osmolality in healthy controls and in patients with first episode schizophrenia.

Authors:  Handan Gunduz-Bruce; Katherine L Narr; Ralitza Gueorguieva; Arthur W Toga; Philip R Szeszko; Manzar Ashtari; Delbert G Robinson; Serge Sevy; John M Kane; Robert M Bilder
Journal:  Psychiatry Res       Date:  2007-03-29       Impact factor: 3.222

Review 4.  Volume regulation in brain cells: cellular and molecular mechanisms.

Authors:  H Pasantes-Morales
Journal:  Metab Brain Dis       Date:  1996-09       Impact factor: 3.584

5.  Clinical practice guideline on diagnosis and treatment of hyponatraemia.

Authors:  Goce Spasovski; Raymond Vanholder; Bruno Allolio; Djillali Annane; Steve Ball; Daniel Bichet; Guy Decaux; Wiebke Fenske; Ewout J Hoorn; Ewout Hoorn; Carole Ichai; Michael Joannidis; Alain Soupart; Robert Zietse; Maria Haller; Sabine van der Veer; Wim Van Biesen; Evi Nagler
Journal:  Intensive Care Med       Date:  2014-02-22       Impact factor: 17.440

6.  Inhibition of ATPases enzyme activities on brain disturbing normal oestrous cycle.

Authors:  J Venugopal; S Ramakrishna
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

Review 7.  Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence.

Authors:  Juan Córdoba; Rita García-Martinez; Macarena Simón-Talero
Journal:  Metab Brain Dis       Date:  2010-03-09       Impact factor: 3.584

Review 8.  Maintenance of cell volume in the central nervous system.

Authors:  K Strange
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

Review 9.  Cell volume regulation: a review of cerebral adaptive mechanisms and implications for clinical treatment of osmolal disturbances: II.

Authors:  H Trachtman
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

10.  Conivaptan and its role in the treatment of hyponatremia.

Authors:  Jalal K Ghali; Jareer O Farah; Suleiman Daifallah; Hassan A Zabalawi; Hammam D Zmily
Journal:  Drug Des Devel Ther       Date:  2009-12-29       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.